beta-lapachone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, JE | 1 |
| Costantini, F | 1 |
| Mims, J | 1 |
| Chen, X | 1 |
| Furdui, CM | 1 |
| Boothman, DA | 1 |
| Kemp, ML | 1 |
1 other study available for beta-lapachone and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Genome-Scale Modeling of NADPH-Driven β-Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma.
Topics: Cell Line, Tumor; Cell Survival; Humans; Kinetics; Models, Genetic; NADP; Naphthoquinones; Proteomic | 2018 |